Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q1 FY19 results · Apr–Jun 2018
Dr. Lal Path Labs reported revenue from operations of ₹292.30 crore and net profit of ₹49.70 crore for Q1 FY19 (Apr–Jun 2018), on a consolidated basis.
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 292.30 | — | — | — | — |
| Other income | 9.40 | — | — | — | — |
| Total income | 301.70 | — | — | — | — |
| Profit before tax | 75.40 | — | — | — | — |
| Net profit for the period | 49.70 | — | — | — | — |
| Attributable to shareholders of the company | 49.40 | — | — | — | — |
| EPS, basic (₹) | 6.00 | — | — | — | — |
| Net margin (%) | 17.0 | — | — |
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 282.90 | — | — | — | — |
| Other income | 10.90 | — | — | — | — |
| Total income | 293.80 | — | — | — | — |
| Profit before tax | 74.90 | — | — | — | — |
| Net profit for the period | 49.80 | — | — | — | — |
| EPS, basic (₹) | 6.05 | — | — | — | — |
| Net margin (%) | 17.6 | — | — |
Consolidated
- Filed with BSE
- 10 Aug 2018, 16:08 IST
- Board meeting
- 10 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Aug 2018, 16:08 IST
- Board meeting
- 10 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE